Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC
Clinical trial NCT00286793 · COMPLETED
Trial details
- NCT number
- NCT00286793
- Sponsor
- Ascenta Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2009-11-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.